News Center
As of May 2026, fifteen states plus the District of Columbia required IVF coverage in state-regulated health insurance, according to a federal proposed rule published in the Federal Register. Yet more than half of workers with employer-sponsored coverage sit in self-insured plans that federal law shields from every one of those state mandates. Many patients living in a mandate state therefore still pay the full cost of IVF out of pocket, often five figures per cycle.
The headline count looks straightforward. A proposed rule on excepted fertility benefits, published in the Federal Register on May 13, 2026, states that 15 states and the District of Columbia currently require health insurance to include IVF benefits. Broader fertility mandates reach further: tracking cited in the same rule, drawing on KFF and RESOLVE data, counts 23 to 25 states plus the District of Columbia as requiring some level of fertility-related care, and 21 states as requiring coverage of fertility preservation. RESOLVE maintains a state-by-state insurance map that readers can check directly.
The number misleads because it describes a legal obligation imposed on a specific type of insurance product, not a guarantee attached to a person or a ZIP code. A mandate binds fully insured plans regulated by the state, meaning plans where an insurance company bears the financial risk and the state insurance department oversees the policy. It does not follow the patient into every plan they might hold. Three separate filters sit between the headline count and an actual covered cycle: the type of plan, the wording of the benefit, and the eligibility clauses written into the statute. Each filter removes patients, and the sections below take them one at a time.
The single most underappreciated fact in American fertility financing is that where you live determines far less than where your employer's plan is funded. The Employee Retirement Income Security Act of 1974, known as ERISA, governs most employer-sponsored health benefit plans. Under ERISA section 514 (29 U.S.C. § 1144), self-insured plans, in which the employer itself pays claims from its own funds and merely hires an administrator to process them, are exempt from state insurance mandates. State IVF laws simply do not reach them.
The scale of this exemption is large. The May 2026 Federal Register proposal notes that self-insured group health plans cover more than half of the people covered by private-sector employer-sponsored health coverage. It also cites estimates that roughly 60 percent of employers offer no fertility benefits at all. Put those two figures together and a substantial share of the workforce lives outside any enforceable IVF coverage requirement, regardless of whether their home state appears on a mandate map.
The exemption also operates in a less visible way. Even among employers that do offer fertility benefits, the Federal Register document observes that these benefits are frequently administered under a separate contract from major medical coverage, often through specialty vendors with their own claims processes and provider networks. A patient may hold a card that says their plan covers fertility care, then discover during an intake call that IVF sits in a separate rider with a separate deductible, a separate lifetime maximum, and a network that excludes the clinic they chose.
Three concrete steps answer the question in most cases:
Patients in mandate states who hold self-insured coverage sometimes assume the state law gives them leverage in an appeal. It does not. An internal appeal against a self-insured plan is decided under the plan document and federal claims procedures, and a state insurance department has no jurisdiction over it. Knowing this early changes strategy: the negotiation happens with the employer's benefits team, not with a regulator.
Often it does not, and this is the second filter that catches patients. State fertility laws fall on a spectrum. At the narrow end, a statute may require insurers to cover the diagnosis of infertility and treatment of its underlying causes, such as surgery for endometriosis or hormonal treatment for ovulation disorders, along with intrauterine insemination. IVF appears nowhere in the required benefit. At the wide end, a statute explicitly names IVF and sets a minimum number of cycles. Both ends get counted as "states with fertility insurance laws" in casual summaries, which is why a patient who reads that their state "has a mandate" may still face a fully self-paid IVF cycle.
The Affordable Care Act adds another layer of wording risk. Under ACA section 1302 and 45 CFR part 156, each state selects an essential health benefits benchmark plan, and individual and small-group insured plans must cover the services in that benchmark. IVF is not one of the ten statutory EHB categories, so whether an individual-market plan in a given state covers it depends on the benchmark the state chose. The Federal Register proposal points out a further consequence: services that fall outside the EHB package are not subject to the protections that attach to EHBs, including the maximum out-of-pocket rules of PHS Act section 2707(b) and the prohibition on annual and lifetime dollar limits in section 2711. In practical terms, a plan can exclude IVF from the out-of-pocket maximum calculation and impose a lifetime dollar cap on fertility care that would be illegal for, say, maternity services. Patients comparing plans during open enrollment should look for the fertility section of the benefit grid rather than the general deductible and out-of-pocket figures.
One more definitional trap deserves its own sentence. Several statutes define "infertility" by reference to a period of unprotected intercourse that failed to produce pregnancy. A patient who needs IVF for a reason unrelated to timed intercourse, such as a genetic condition requiring embryo testing or a medical need to preserve fertility before gonadotoxic cancer treatment, may fall outside the statutory definition entirely, even in a state with a strong mandate. Fertility preservation mandates exist in 21 states per the RESOLVE figures cited federally, but they typically cover patients facing medical treatments that impair fertility, not patients delaying childbearing for personal or career reasons.
The third filter operates inside the statutes themselves. The May 2026 Federal Register document is explicit that coverage limitations are present in all state IVF coverage requirements. Four clause types do most of the dividing.
Many mandates impose a benefit-specific waiting period: the patient must have failed to achieve pregnancy, or failed to carry a pregnancy to term, for a defined span before IVF becomes payable. The federal proposal notes that this period may vary with the age of the patient, a design that reflects clinical guidance on age-related decline but also delays older patients the most. Some states soften the clause by allowing a licensed physician's infertility diagnosis to unlock benefits before the waiting period runs. The difference between these two versions can be measured in months of treatment time, which matters directly for patients in their late thirties. Ask your clinic's financial counselor to identify which version applies to your policy.
Per the Federal Register summary, limits on the number of covered IVF cycles or egg retrievals range from one cycle to three, with three being the more common ceiling. Dollar-based lifetime caps in state laws run from as low as $15,000 to as high as $100,000. Both numbers interact with reality in an unkind way: a single cycle including medications commonly consumes a large fraction of a $15,000 cap, while a patient who needs multiple transfers after failed cycles can exhaust a three-cycle cap long before achieving a live birth. The cap is a plan-design decision, not a clinical recommendation, and patients should build a budget that assumes the cap will run out.
Older statutes in several states define infertility through intercourse between partners attempting to conceive together, language that patient-advocacy groups including RESOLVE have documented as excluding same-sex couples and single patients from mandated coverage in those jurisdictions. Newer or amended statutes have moved toward functionally inclusive definitions, so the same state can treat two patients with identical diagnoses differently depending on which statutory text governs their policy year. This is a clause-level question, and the answer lives in the statute text and the plan document, not in the state's reputation.
Several mandates write an upper age limit directly into the statute, ending coverage for women past a specified age regardless of ovarian reserve or prior response to stimulation. A patient who is covered at 39 and turns 40 mid-treatment can lose eligibility between the retrieval and the frozen transfer. Clinics that deal with insured patients regularly, such as Shady Grove Fertility in Maryland or CNY Fertility in New York, both operating in states with IVF mandates, generally verify these clauses during insurance authorization before any cycle begins. Ask specifically whether your age on the date of transfer or the date of retrieval controls eligibility.
On October 15, 2025, the administration announced an effort to expand employer fertility benefits, accompanied by guidance known as FAQs About Affordable Care Act Implementation Part 72, issued under Executive Order 14216. The Departments of Labor, Health and Human Services, and Treasury followed with a proposed rule, published May 13, 2026, that would establish fertility benefits as a new category of limited excepted benefits. The design goal is to make it administratively easier for employers, including self-insured employers, to offer standalone fertility coverage outside the main medical plan.
Two boundaries matter for patients reading the news. The rule is proposed, not final, and its text has gone through comment periods before taking effect. Even once effective, it creates a pathway for employers to offer benefits voluntarily; it imposes no requirement on any employer and creates no individual entitlement. A patient whose self-insured plan excludes IVF in 2026 has gained a new argument to raise with their HR department, and nothing more. The structural exemption of self-insured plans from state mandates remains untouched by this rulemaking.
Where no mandate, rider, or employer benefit applies, the patient funds the cycle directly. Across the American market, a single IVF cycle's clinic fee commonly falls in the low-to-mid five figures before medications, and fertility medications typically add several thousand dollars per cycle; exact figures vary widely by clinic, protocol, and medication regimen, and published prices should be confirmed with each program's official schedule. Patients with a mandate or rider pay less in total but still carry meaningful costs: deductibles and coinsurance on a covered cycle, medication copays that can reach thousands of dollars, and every service the statute excludes, such as embryo genetic testing or anesthesia in some states. Patients whose coverage caps out mid-treatment face the full self-pay rate for any remaining transfers.
Financial counseling, multi-cycle packages, and refund or shared-risk style programs exist at many larger practices, and several clinics maintain dedicated self-pay schedules and financing arrangements. Terms differ substantially between programs, so request the written self-pay schedule and any package agreement before committing.
Rather than ranking programs, it helps to match clinic type to funding situation. Three examples illustrate the range, with all pricing and outcome figures subject to each program's official published data:
The practical rule: patients with potential coverage should favor programs with a dedicated insurance authorization team, and self-pay patients should favor programs with transparent, published package pricing.
The gap between a state mandate map and a paid-for IVF cycle is where most American fertility budgets are actually decided. Closing that gap requires reading three documents: the plan's funding structure, the statute's benefit definitions, and the eligibility clauses. Patients who verify all three before their first injection avoid the most expensive version of this lesson, the one learned halfway through stimulation.
